GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 6 24-6, 2001, Pages

  Hawgood, Samuel ^a,b   Akiyama, Jennifer ^a   Brown, Cynthia ^a   Allen, Lennell ^a   Li, Gordon ^a   Poulain, Francis R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Granulocyte macrophage colony stimulating factor; Inflammation; Lung surfactant; Surfactant protein D; Type II cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUNG SURFACTANT; PHOSPHOLIPID; PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; LUNG ALVEOLUS CELL TYPE 2; LUNG LAVAGE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 0034984142     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.6.l1148     Document Type: Article

References (42)

1. Characterization of the mouse collectin gene locus
2. Phosphorus assay in column chromatography
3. Secretion of cytokines by rat alveolar epithelial cells: Possible regulatory role for SP-A
4. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production
5. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
6. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation
7. Collectins and pulmonary innate immunity
8. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
9. Innate immunity
10. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin
11. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice
12. Degree of lung maturity determines the direction of the interleukin-1-induced effect on the expression of surfactant proteins
13. Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage
14. Binding and uptake of surfactant protein D by freshly isolated rat alveolar type II cells
15. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice
16. Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice
17. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation
18. Alterations in surfactant homeostasis resulting from SP-D deficiency
19. IL-4 increases surfactant and regulates metabolism in vivo
20. Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung
21. Changes in the amount of lung and airway phosphatidylcholine in 0.5-12.5-day-old rabbits
22. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo
23. Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A
24. M-CSF and GM-CSF promote alveolar macrophage differentiation into multinucleated giant cells with distinct phenotypes
25. Alterations of surfactant lipid turnover in silicosis: Evidence of a role for surfactant-associated protein A (SP-A)
26. Subfractionation of lung surfactant. Implications for metabolism and surface activity
27. Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophages
28. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal
29. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation
30. Hypertrophic alveolar type II cells from silica treated rats are committed to DNA synthesis in vitro
31. Ultrastructure of phospholipid mixtures reconstituted with surfactant proteins B and D
32. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5
33. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
34. The catabolism of lung surfactant by alveolar macrophages
35. Surfactant secretion and clearance in the newborn
36. Aerosolized endotoxin is immediately bound by pulmonary surfactant protein D in vivo
37. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens
38. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma
39. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice
40. Transforming growth factor-beta inhibits surfactant protein A expression in vitro
41. Effects of TNF-α and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro
42. Immunomodulatory functions of surfactant